药学与临床研究2024,Vol.32Issue(3) :267-269.

4例行左心室辅助装置植入术患者的围术期抗栓治疗分析

Analysis and Monitoring of Perioperative Antithrombotic Therapy in 4 Pa-tients Undergoing Left Ventricular Assist Device Implantation

史金平 王立珍 张琰 唐亚娟 路小寒 白娟 洪术霞
药学与临床研究2024,Vol.32Issue(3) :267-269.

4例行左心室辅助装置植入术患者的围术期抗栓治疗分析

Analysis and Monitoring of Perioperative Antithrombotic Therapy in 4 Pa-tients Undergoing Left Ventricular Assist Device Implantation

史金平 1王立珍 1张琰 1唐亚娟 1路小寒 1白娟 1洪术霞1
扫码查看

作者信息

  • 1. 西安国际医学中心医院药学部,西安 710100
  • 折叠

摘要

临床药师通过监护4例既往长期抗血栓治疗,拟行左心室辅助装置植入术患者的围术期抗血栓治疗,旨在总结该类患者围术期抗血栓治疗的监护重点.结果提示,临床药师以术前讨论的方式,评估患者血栓与出血风险,制定手术前抗血栓药物的停药与桥接时机,且通过药学监护,调整术后抗血栓药物的剂量与给药时机,识别药物相互作用,可降低患者围术期血栓与出血事件发生率.

Abstract

Clinical pharmacists monitored perioperative antithrombotic therapy in four patients who un-derwent left ventricular assist device implantation after long-term anticoagulation therapy,aiming to summa-rize the focus of perioperative antithrombotic therapy in this patient population.The results revealed that clinical pharmacists assessed the thrombotic and bleeding risks of patients through preoperative discussions,determined the timing of discontinuing antithrombotic medications and bridging therapy before surgery,and adjusted the dosage and administration timing of postoperative antithrombotic medications through pharma-ceutical monitoring,they also identified drug interactions,which reduced the incidence of perioperative thrombotic or bleeding events in patients.

关键词

左心室辅助装置/人工心脏/围手术期/抗凝管理/药学监护

Key words

Left ventricular assist device/Artificial heart/Perioperative period/Anticoagulant manage-ment/Pharmaceutical monitoring

引用本文复制引用

基金项目

西安国际医学中心医院青年课题(2023QN13)

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
参考文献量3
段落导航相关论文